ArticleThe oncologist2025

Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinib.

Federico Villanacci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.